The insider selling is small relative to market cap and likely reflects routine portfolio diversification or tax planning rather than a bearish signal. Monitor for any upcoming 8-K or press release that could explain the timing; absent that, the cluster is not actionable on its own.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 31 $62.45entry
- T+1 · 3mo ago −3.96%α −3.27% · $59.98
- T+5 · 2mo ago +5.04%α +5.19% · $65.60
- T+20 · 7w ago +43.93%α +43.87% · $89.89
- T+54 · todayOpen
- T+60 · in 7d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of insider selling at 10x Genomics (TXG) over the past week saw the CEO, CFO, and a director collectively sell $2.21M in open-market shares. While the dollar amount is modest relative to the $8.4B market cap (0.03%), the participation of the CEO and CFO in the same window elevates the signal.
Key Financial Metrics
Key Facts
- CEO Serge Saxonov sold 28,986 shares for $1.84M across three transactions on Aug 24 and Aug 26.
- CFO Adam Taich sold 17,166 shares for $1.08M on Aug 24.
- Director Shehnaaz Suliman sold 2,207 shares for $140K on Aug 24.
- Benjamin Hindson (See Remarks) sold 13,818 shares for $871K on Aug 24.
- Total cluster value of $2.21M represents ~0.03% of TXG's $8.4B market cap.
- The cluster is a pure sell, no open-market purchases were reported.
Financial Impact
Total insider sales of $2.21M, or 0.03% of market cap.
Risk Factors
- Insider selling could accelerate if the stock rallies, creating overhead supply.
- The CEO and CFO selling simultaneously, even in small amounts, may be interpreted negatively by momentum traders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TXG-1787961670217 |
Track record
28 reports on TXG
1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $58.19 +5.04% settles Feb 12
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $58.19 −10.55% settles Feb 5
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $58.19 −10.55% settles Feb 5
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $58.19 −1.84% settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $58.19 −10.87% settles Feb 1
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $58.19 −18.67% settles Jan 21
- Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $58.19 −24.70% settles Jan 5
- Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $58.19 −32.11% settles Dec 21
- Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $58.19 −23.05% settles Dec 17
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers